SOURCE: Lyonbiopole

Lyonbiopole

May 03, 2016 14:32 ET

BIO 2016: LYONBIOPOLE Will Unite Life Science Groups at the BIO International Convention French Pavilion

Booth 705, June 6th-9th, San Francisco, CA

LYON, FRANCE--(Marketwired - May 03, 2016) - LYONBIOPOLE, the organization dedicated to the life science cluster in French Auvergne-Rhône-Alpes Region, will unite twenty-five groups from the region at the 2016 edition of the BIO International Convention.

This French region is recognized as an international life science cluster. It's a center for research and high-level education, making specialized talent easily available. LYONBIOPOLE further drives innovation with attractive infrastructure for business.

LYONBIOPOLE is the gateway to life science innovation in the Auvergne Rhône-Alpes Region. The group supports ambitious projects and companies to encourage technologies, products and services for personalized medicine that benefits the patient.

LYONBIOPOLE will bring together twenty-five strategic life science companies in the French Pavilion at the BIO International Convention. The LYONBIOPOLE booth will include:

  • Alaxia
  • VOXCAN
  • Alizé Pharma
  • Theranexus
  • CELLIPSE
  • ADOCIA
  • CapEval Pharma
  • elsalys biotech
  • MaaT Pharma
  • Prediction BioSciences
  • ImmunID
  • Neolys Diagnostics
  • LXRepair
  • Inovotion
  • CYTOO
  • TransCure bioServices SAS
  • genOway
  • EVEON
  • Flamel
  • Erytech
  • Enyo
  • Novasep
  • CEA LETI
  • ACCINOV
  • BIOASTER

To book an appointment and meet with LYONBIOPOLE and the organizations they are bringing to the BIO International Convention, please contact Dalyce Semko Suanez at (403)869-3259.

About Lyonbiopole

As a Bio Cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne Rhône-Alpes Region. The cluster supports ambitious projects and companies in the health sector (infectious diseases, cancer, nutrition, metabolic diseases.). Their aim is to support innovative technologies, products and services for more personalized medicine that benefits the patient.

Lyonbiopole is involved in 4 strategic areas: human medicine; veterinary medicine; in vitro diagnostics; medical devices. Its missions are: 1) to promote the emergence of innovative R&D collaborative projects; 2) to support SME for strategic partnerships, access to private investors, expertise and training; 3) to foster SMB Internationalization and the cluster position at the EU and International levels; 4) to give access to high-level dedicated facilities.

Lyonbiopole received the "Gold Label" by ECEI in 2014. In 2015, Lyonbiopole represented 190 members: 5 world-class leaders including its founders (Sanofi Pasteur, bioMérieux, Merial, BD); 17 Research Centers including 3 Hospital University Centers; 168 SMEs.

More information: www.lyonbiopole.com

Contact Information